Open access
Aug 2026
EP377 - ECE_3691 - FABP4 and fatty liver index in obesity: insights across metabolic health categories
The findings support FABP4 as a potential biomarker reflecting both metabolic phenotype and liver steatosis in obesity and further studies are needed to clarify the role of FABP4 as a non-invasive indicator of NAFDL.
Barbara Bromińska, A. Krygier, E. Milewska-Kobos et al.
· European Journal of Endocrin... · 0 citations